Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules

Immunogenetics

Volumn 39, Issue 4, 1994, Pages 230-242

  Falk, Kirsten ^a   Rötzschke, Olaf ^a   Stevanovíc, Stefan ^b   Jung, Günther ^b   Rammensee, Hans Georg ^a  

^a MAX PLANCK INST FÜR BIOLOGIE   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; LIGAND; PEPTIDE; PROLINE;

AMINO ACID SEQUENCE; ARTICLE; CELL CULTURE; CELL LINE; GENETIC ANALYSIS; IMMUNOGENETICS; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN PROCESSING; SEQUENCE ANALYSIS;

ALLELES; AMINO ACID SEQUENCE; HLA-DP ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMAN; LIGANDS; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN CONFORMATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SUPPORT, NON-U.S. GOV'T;

EID: 0028157322     PISSN: 00937711     EISSN: 14321211     Source Type: Journal    
DOI: 10.1007/BF00188785     Document Type: Article

References (43)

1. 2 protein domains
2. Membrane-bound peptidases of lymphocytes — functional implications
3. Nomenclature for factors of the HLA system, 1991
4. A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules
5. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1
6. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size
7. Mutations that impair a posttranscriptional step in expression of HLA-A and-B antigens
8. The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86
9. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
10. b
11. Specificity pockets for the side chains of peptide antigens in HLA-Aw68
12. Structural analysis of class II major histocompatibility complex proteins
13. Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line
14. Immunochemically purified DR antigens in liposomes stimulate xenogeneic cytolytic T cells in secondary in vitro cultures
15. Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle
16. Identification of a motif for HLA-DR1 binding peptides using M13 display libraries
17. Conformatinal and structural characteristics of peptides binding to HLA-DR molecules
18. d
19. Peptide binding to HLA-DR1: A peptide with most residues substituted to alanine retains MHC binding
20. Identification of self peptides bound to purified HLA-B27
21. Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognition
22. Self-peptide released from class II HLA-DR1 exhibits a hydrophobic two-residue contact motif
23. A simple method for displaying the hydrophatic character of a protein
24. Two populations of la-like molecules on a human B cell line
25. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation
26. Natural peptide ligand motifs of two HLA molecules associated with myasthenia gravis
27. Emerging principles for the recognition of peptide antigens by MHC class I molecules
28. In vitro peptide binding to soluble empty class I major histocompatibility complex molecules isolated from transfected Drosophila melanogaster cells
29. k
30. On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs
31. Universally immunogenic T cell epitopes: Promiscuous binding to human MHC class II and promiscuous recognition by T cells
32. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells
33. Peptides naturally presented by MHC class I molecules
34. Sequence analysis of peptides bound to MHC class II molecules
35. Truncation variants of peptides isolated from MHC class-II molecules suggest sequence motifs
36. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6A resolution
37. Dipeptidyl peptidase-IV in the immune system — effects of specific enzyme-inhibitors on activity of dipeptidyl peptidase-IV and proliferation of human lymphocytes
38. Structural requirements for the interaction between class II MHC molecules and peptide antigens
39. Production of human cells expressing individual transferred HLA-A, -B, -C genes using an HLA-A, -B,-C null human cell line
40. Transfer and expression of three cloned human non-HLA-A, -B, C class I major histocompatibility complex genes in mutant lymphoblastoid cells
41. A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules
42. Detection of a novel human class II HLA antigen
43. The HLA-A,B negative mutant-cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon